Liraglutide Exerts Protective Effects by Downregulation of <i>PPARγ</i>, <i>ACSL1</i> and <i>SREBP-1c</i> in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug-Induced Steatosis

(1) Background: With the aging of the population and polypharmacy encountered in the elderly, drug-induced steatosis (DIS) has become frequent cause of non-alcoholic steatosis (NAS). Indeed, NAS and DIS may co-exist, making the ability to distinguish between the entities ever more important. The aim...

Full description

Bibliographic Details
Main Authors: Tea Omanovic Kolaric, Tomislav Kizivat, Vjera Mihaljevic, Milorad Zjalic, Ines Bilic-Curcic, Lucija Kuna, Robert Smolic, Aleksandar Vcev, George Y. Wu, Martina Smolic
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Current Issues in Molecular Biology
Subjects:
Online Access:https://www.mdpi.com/1467-3045/44/8/239
_version_ 1797410786616803328
author Tea Omanovic Kolaric
Tomislav Kizivat
Vjera Mihaljevic
Milorad Zjalic
Ines Bilic-Curcic
Lucija Kuna
Robert Smolic
Aleksandar Vcev
George Y. Wu
Martina Smolic
author_facet Tea Omanovic Kolaric
Tomislav Kizivat
Vjera Mihaljevic
Milorad Zjalic
Ines Bilic-Curcic
Lucija Kuna
Robert Smolic
Aleksandar Vcev
George Y. Wu
Martina Smolic
author_sort Tea Omanovic Kolaric
collection DOAJ
description (1) Background: With the aging of the population and polypharmacy encountered in the elderly, drug-induced steatosis (DIS) has become frequent cause of non-alcoholic steatosis (NAS). Indeed, NAS and DIS may co-exist, making the ability to distinguish between the entities ever more important. The aim of our study was to study cell culture models of NAS and DIS and determine the effects of liraglutide (LIRA) in those models. (2) Methods: Huh7 cells were treated with oleic acid (OA), or amiodarone (AMD) to establish models of NAS and DIS, respectively. Cells were treated with LIRA and cell viability was assessed by MTT, lipid accumulation by Oil-Red-O staining and triglyceride assay, and intracellular signals involved in hepatosteatosis were quantitated by RT-PCR. (3) Results: After exposure to various OA and AMD concentrations, those that achieved 80% of cells viabilities were used in further experiments to establish NAS and DIS models using 0.5 mM OA and 20 µM AMD, respectively. In both models, LIRA increased cell viability (<i>p</i> < 0.01). Lipid accumulation was increased in both models, with microsteatotic pattern in DIS, and macrosteatotic pattern in NAS which corresponds to greater triglyceride accumulation in latter. LIRA ameliorated these changes (<i>p</i> < 0.001), and downregulated expression of lipogenic <i>ACSL1</i>, <i>PPARγ</i>, and <i>SREBP-1c</i> pathways in the liver (<i>p</i> < 0.01) (4) Conclusions: LIRA ameliorates hepatocyte steatosis in Huh7 cell culture models of NAS and DIS.
first_indexed 2024-03-09T04:35:15Z
format Article
id doaj.art-c815af59f67c496a9a50dce02969cadf
institution Directory Open Access Journal
issn 1467-3037
1467-3045
language English
last_indexed 2024-03-09T04:35:15Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Current Issues in Molecular Biology
spelling doaj.art-c815af59f67c496a9a50dce02969cadf2023-12-03T13:29:02ZengMDPI AGCurrent Issues in Molecular Biology1467-30371467-30452022-08-014483465348010.3390/cimb44080239Liraglutide Exerts Protective Effects by Downregulation of <i>PPARγ</i>, <i>ACSL1</i> and <i>SREBP-1c</i> in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug-Induced SteatosisTea Omanovic Kolaric0Tomislav Kizivat1Vjera Mihaljevic2Milorad Zjalic3Ines Bilic-Curcic4Lucija Kuna5Robert Smolic6Aleksandar Vcev7George Y. Wu8Martina Smolic9Department of Pharmacology and Biochemistry, Faculty of Dental Medicine and Health Osijek, Crkvena 21, 31000 Osijek, CroatiaDepartment of Nuclear Medicine and Oncology, Faculty of Medicine Osijek, J. Huttlera 4, 31000 Osijek, CroatiaDepartment of Pharmacology and Biochemistry, Faculty of Dental Medicine and Health Osijek, Crkvena 21, 31000 Osijek, CroatiaDepartment of Molecular Medicine and Biotechnology, Faculty of Medicine Rijeka, B. Branchetta 20, 51000 Rijeka, CroatiaDepartment of Pharmacology, Faculty of Medicine Osijek, J. Huttlera 4, 31000 Osijek, CroatiaDepartment of Pharmacology and Biochemistry, Faculty of Dental Medicine and Health Osijek, Crkvena 21, 31000 Osijek, CroatiaDepartment of Pharmacology and Biochemistry, Faculty of Dental Medicine and Health Osijek, Crkvena 21, 31000 Osijek, CroatiaDepartment of Pathophysiology and Physiology with Immunology, Faculty of Dental Medicine and Health Osijek, Crkvena 21, 31000 Osijek, CroatiaDepartment of Medicine, Division of Gastroenterology-Hepatology, University of Connecticut Health Center, 135 Dowling Way, Farmington, CT 06030, USADepartment of Pharmacology and Biochemistry, Faculty of Dental Medicine and Health Osijek, Crkvena 21, 31000 Osijek, Croatia(1) Background: With the aging of the population and polypharmacy encountered in the elderly, drug-induced steatosis (DIS) has become frequent cause of non-alcoholic steatosis (NAS). Indeed, NAS and DIS may co-exist, making the ability to distinguish between the entities ever more important. The aim of our study was to study cell culture models of NAS and DIS and determine the effects of liraglutide (LIRA) in those models. (2) Methods: Huh7 cells were treated with oleic acid (OA), or amiodarone (AMD) to establish models of NAS and DIS, respectively. Cells were treated with LIRA and cell viability was assessed by MTT, lipid accumulation by Oil-Red-O staining and triglyceride assay, and intracellular signals involved in hepatosteatosis were quantitated by RT-PCR. (3) Results: After exposure to various OA and AMD concentrations, those that achieved 80% of cells viabilities were used in further experiments to establish NAS and DIS models using 0.5 mM OA and 20 µM AMD, respectively. In both models, LIRA increased cell viability (<i>p</i> < 0.01). Lipid accumulation was increased in both models, with microsteatotic pattern in DIS, and macrosteatotic pattern in NAS which corresponds to greater triglyceride accumulation in latter. LIRA ameliorated these changes (<i>p</i> < 0.001), and downregulated expression of lipogenic <i>ACSL1</i>, <i>PPARγ</i>, and <i>SREBP-1c</i> pathways in the liver (<i>p</i> < 0.01) (4) Conclusions: LIRA ameliorates hepatocyte steatosis in Huh7 cell culture models of NAS and DIS.https://www.mdpi.com/1467-3045/44/8/239NASamiodaroneliraglutideHuh7 cell line
spellingShingle Tea Omanovic Kolaric
Tomislav Kizivat
Vjera Mihaljevic
Milorad Zjalic
Ines Bilic-Curcic
Lucija Kuna
Robert Smolic
Aleksandar Vcev
George Y. Wu
Martina Smolic
Liraglutide Exerts Protective Effects by Downregulation of <i>PPARγ</i>, <i>ACSL1</i> and <i>SREBP-1c</i> in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug-Induced Steatosis
Current Issues in Molecular Biology
NAS
amiodarone
liraglutide
Huh7 cell line
title Liraglutide Exerts Protective Effects by Downregulation of <i>PPARγ</i>, <i>ACSL1</i> and <i>SREBP-1c</i> in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug-Induced Steatosis
title_full Liraglutide Exerts Protective Effects by Downregulation of <i>PPARγ</i>, <i>ACSL1</i> and <i>SREBP-1c</i> in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug-Induced Steatosis
title_fullStr Liraglutide Exerts Protective Effects by Downregulation of <i>PPARγ</i>, <i>ACSL1</i> and <i>SREBP-1c</i> in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug-Induced Steatosis
title_full_unstemmed Liraglutide Exerts Protective Effects by Downregulation of <i>PPARγ</i>, <i>ACSL1</i> and <i>SREBP-1c</i> in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug-Induced Steatosis
title_short Liraglutide Exerts Protective Effects by Downregulation of <i>PPARγ</i>, <i>ACSL1</i> and <i>SREBP-1c</i> in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug-Induced Steatosis
title_sort liraglutide exerts protective effects by downregulation of i pparγ i i acsl1 i and i srebp 1c i in huh7 cell culture models of non alcoholic steatosis and drug induced steatosis
topic NAS
amiodarone
liraglutide
Huh7 cell line
url https://www.mdpi.com/1467-3045/44/8/239
work_keys_str_mv AT teaomanovickolaric liraglutideexertsprotectiveeffectsbydownregulationofippargiiacsl1iandisrebp1ciinhuh7cellculturemodelsofnonalcoholicsteatosisanddruginducedsteatosis
AT tomislavkizivat liraglutideexertsprotectiveeffectsbydownregulationofippargiiacsl1iandisrebp1ciinhuh7cellculturemodelsofnonalcoholicsteatosisanddruginducedsteatosis
AT vjeramihaljevic liraglutideexertsprotectiveeffectsbydownregulationofippargiiacsl1iandisrebp1ciinhuh7cellculturemodelsofnonalcoholicsteatosisanddruginducedsteatosis
AT miloradzjalic liraglutideexertsprotectiveeffectsbydownregulationofippargiiacsl1iandisrebp1ciinhuh7cellculturemodelsofnonalcoholicsteatosisanddruginducedsteatosis
AT inesbiliccurcic liraglutideexertsprotectiveeffectsbydownregulationofippargiiacsl1iandisrebp1ciinhuh7cellculturemodelsofnonalcoholicsteatosisanddruginducedsteatosis
AT lucijakuna liraglutideexertsprotectiveeffectsbydownregulationofippargiiacsl1iandisrebp1ciinhuh7cellculturemodelsofnonalcoholicsteatosisanddruginducedsteatosis
AT robertsmolic liraglutideexertsprotectiveeffectsbydownregulationofippargiiacsl1iandisrebp1ciinhuh7cellculturemodelsofnonalcoholicsteatosisanddruginducedsteatosis
AT aleksandarvcev liraglutideexertsprotectiveeffectsbydownregulationofippargiiacsl1iandisrebp1ciinhuh7cellculturemodelsofnonalcoholicsteatosisanddruginducedsteatosis
AT georgeywu liraglutideexertsprotectiveeffectsbydownregulationofippargiiacsl1iandisrebp1ciinhuh7cellculturemodelsofnonalcoholicsteatosisanddruginducedsteatosis
AT martinasmolic liraglutideexertsprotectiveeffectsbydownregulationofippargiiacsl1iandisrebp1ciinhuh7cellculturemodelsofnonalcoholicsteatosisanddruginducedsteatosis